Monique Ummelen
Maastricht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Monique Ummelen.
The Journal of Pathology | 2004
Anton H. N. Hopman; Frank Smedts; W. Dignef; Monique Ummelen; G.S. Sonke; M. Mravunac; G.P. Vooijs; E.J. Speel; Frans C. S. Ramaekers
Cervical intraepithelial neoplasia (CIN I, II, and III) and cases of CIN III associated with micro‐invasive cervical carcinoma (CIN III & mCA) were analysed for evidence of episomal or integrated human papillomavirus (HPV) 16/18 DNA by fluorescence in situ hybridization (FISH). In parallel, numerical aberrations of chromosomes 1, 17, and X were determined in these lesions as indicators of genomic instability. HPV 16/18 DNA was present in 2 of 12 CIN I, 19 of 23 CIN II/III, and 10 of 12 CIN III & mCA. None of the CIN I and only two of the 19 HPV 16/18‐positive solitary CIN II/III showed an integrated HPV pattern. However, all ten cases of HPV‐positive CIN III & mCA showed this pattern. Transition of CIN II/III to CIN III & mCA therefore correlates strongly with viral integration (p < 0.001). Chromosomal aberrations were detected in 23 of 31 HPV 16/18‐positive lesions (14 solitary CIN I–III and nine CIN III & mCA) and 5 of 16 HPV‐negative lesions. Nine of 21 HPV 16/18‐positive solitary CIN I–III showed tetrasomy for all chromosomes tested, while trisomies for a single chromosome were seen in a further five of these HPV‐positive lesions. In eight of ten HPV‐positive CIN III & mCA, predominantly aneusomies and/or polysomies were detected. A significant correlation (p < 0.02) was found between the chromosome copy number and the physical status of HPV, indicating that in its episomal form HPV induces genomic changes such as tetrasomies and single trisomies, while HPV integration correlates with aneusomies and polysomies, predominantly detected in CIN III & mCA. These data indicate that integration of HPV 16/18 DNA is a pivotal step in the transition of CIN to micro‐invasive carcinoma. Copyright
Genes, Chromosomes and Cancer | 2002
Peter H Wessels; Albert Twijnstra; Alfons G. H. Kessels; Bela Krijne-Kubat; Paul H. M. H. Theunissen; Monique Ummelen; Frans C. S. Ramaekers; Anton H. N. Hopman
The clinical course of astrocytoma grade 2 (A2) is highly variable and is not reflected by morphological characteristics. Earlier studies using small series of A2 cases suggest that in situ hybridization (ISH) with chromosome‐specific DNA probes allows for frequent detection of aneusomy 1, trisomy 7, and monosomy 10. The role of trisomy 7 in astrocytoma carcinogenesis is disputed, however, because of its presence in non‐neoplastic brain tissue, as detected by karyotyping. Our objective was to investigate whether there was a correlation between chromosomal aberrations and survival in a series of 47 cases of A2. All cases were evaluated for numerical aberrations of chromosomes 1, 7, and 10 by ISH. Chromosomal aberrations were detected in 68% of cases of A2. Trisomy/polysomy 7 was seen in 31 cases (66%), 22 of which (47%) had a high percentage of this numerical aberration. Only 11 of these 22 cases also showed aneusomy for 1 or 10. No cells or only a few cells with aberrations were detected in non‐neoplastic control samples. Using Kaplan‐Meier analysis, trisomy/polysomy 7 correlated significantly with shorter survival. Hence, as determined by ISH, trisomy/polysomy 7 is absent in non‐neoplastic brain tissue and is frequently detected in A2, correlating with the malignant progression of the disease.
Neurology | 2001
Peter H Wessels; Anton H. N. Hopman; Monique Ummelen; B. Krijne-Kubat; Frans C. S. Ramaekers; Albert Twijnstra
The authors examined the use of chromosomal analysis by in situ hybridization to differentiate between nonneoplastic reactive gliosis and astrocytomas in cases in which routine histology was inconclusive. Numerical chromosomal aberrations were found in 80% of low-grade astrocytoma specimens and in none of the reactive gliosis specimens. Aneusomic tumor cells were detected in four of 13 stereotactic samples with an initially inconclusive tissue diagnosis, three of which were later diagnosed as astrocytoma. The in situ hybridization procedure may have additional value in the differential diagnosis of reactive gliosis versus low-grade astrocytoma.
Genes, Chromosomes and Cancer | 2004
Peter H Wessels; Albert Twijnstra; Bela Kubat; Monique Ummelen; Sandra M.H. Claessen; Raphael Sciot; Adrian Merlo; Frans C. S. Ramaekers; Ernst J. M. Speel; Anton H. N. Hopman
In the literature, it has been suggested that loss of the 10q25‐26 region, including the DMBT1 gene (10q25.3), is correlated with initiation and/or malignant progression of astrocytomas, although the results of the studies on the loss of heterozygosity that led to this assumption are not unequivocal. For this reason, using double‐target fluorescence in situ hybridization, we compared copy number changes of 10q25.3 to those of the pericentromeric region (10q12) in 10 cases each of astrocytoma grades II and IV. The same specimens were analyzed for copy number changes of chromosome 1, as a marker for polyploidy, and chromosome 7, which is often gained in astrocytomas of all grades. Our results show that selective loss of the 10q25.3 region was present in 2 of 10 specimens in both astrocytoma grade II and grade IV, occurring only in tumors with polysomy for 10q12. Furthermore, astrocytoma grade II often showed polyploidy for chromosomes 1, 7, and 10 (8 of 10 specimens). In addition, astrocytoma grade IV frequently exhibited losses of chromosome 10 in a high percentage of nuclei. Although based on a small number of cases, the results clearly show that loss of the 10q25.3 region is uncommon in astrocytoma grade II and mostly coincident with loss of chromosome 10 in grade IV tumors. These data indicate that selective loss of the 10q25.3 region, including the DMBT1 gene, is not an initiating event in the genesis of astrocytoma grade II.
Journal of General Virology | 2017
Boštjan J. Kocjan; Lea Hošnjak; Joško Račnik; Marko Zadravec; Nejc Bakovnik; Blaž Cigler; Monique Ummelen; Anton H. N. Hopman; Nina Gale; Tanja Švara; Mitja Gombač; Mario Poljak
Phodopus sungorus papillomavirus type 1 (PsuPV1), naturally infecting Siberian hamsters (Phodopus sungorus) and clustering in the genus Pipapillomavirus (Pi-PV), is only the second PV type isolated from the subfamily of hamsters. In silico analysis of three independent complete viral genomes obtained from cervical adenocarcinoma, oral squamous cell carcinoma and normal oral mucosa revealed that PsuPV1 encodes characteristic viral proteins (E1, E2, E4, E6, E7, L1 and L2) with conserved functional domains and a highly conserved non-coding region. The overall high prevalence (102/114; 89.5 %) of PsuPV1 infection in normal oral and anogenital mucosa suggests that asymptomatic infection with PsuPV1 is very frequent in healthy Siberian hamsters from an early age onward, and that the virus is often transmitted between both anatomical sites. Using type-specific real-time PCR and chromogenic in situ hybridization, the presence of PsuPV1 was additionally detected in several investigated tumours (cervical adenocarcinoma, cervical adenomyoma, vaginal carcinoma in situ, ovarian granulosa cell tumour, mammary ductal carcinoma, oral fibrosarcoma, hibernoma and squamous cell papilloma) and normal tissues of adult animals. In the tissue sample of the oral squamous cell carcinoma individual, punctuated PsuPV1-specific in situ hybridization spots were detected within the nuclei of infected animal cells, suggesting viral integration into the host genome and a potential etiological association of PsuPV1 with sporadic cases of this neoplasm.
International Journal of Oncology | 2004
Marjan Harmsma; Monique Grommé; Monique Ummelen; Wendy Dignef; Karel Jan Tusenius; Frans C. S. Ramaekers
Drug Research | 2011
Marjan Harmsma; Monique Ummelen; Wendy Dignef; Karel Jan Tusenius; Frans C. S. Ramaekers
Pathology & Oncology Research | 2018
Margot M. Koeneman; Irene Tveiterås Øvestad; Emiel A.M. Janssen; Monique Ummelen; Roy F.P.M. Kruitwagen; Anton H. N. Hopman; Arnold J. Kruse
International Journal of Oncology | 2004
Bert Schutte; M. Harmsa; G. Costongs; M. Henfling; Monique Ummelen; W. Dignef; Frans C. S. Ramaekers
Total Quality Management & Business Excellence | 1996
Christina E. M. Voorter; Monique Ummelen; Frans C. S. Ramaekers; Anton H. N. Hopman